Barclays PLC Fibrogen Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Fibrogen Inc stock. As of the latest transaction made, Barclays PLC holds 1 shares of FGEN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$0.33 - $1.26 $9,658 - $36,877	-29,268 Reduced 100.0%	1 $0
Q2 2024 Aug 14, 2024	SELL	$0.89 - $2.36 $31,339 - $83,102	-35,213 Reduced 54.61%	29,269 $26,000
Q1 2024 May 15, 2024	SELL	$0.73 - $2.73 $124,783 - $466,655	-170,936 Reduced 72.61%	64,482 $151,000
Q4 2023 Feb 15, 2024	BUY	$0.38 - $0.91 $78,701 - $188,470	207,110 Added 731.63%	235,418 $209,000
Q3 2023 Nov 07, 2023	SELL	$0.79 - $2.83 $128,331 - $459,719	-162,445 Reduced 85.16%	28,308 $24,000
Q2 2023 Aug 03, 2023	BUY	$2.49 - $20.59 $49,979 - $413,282	20,072 Added 11.76%	190,753 $514,000
Q1 2023 May 04, 2023	SELL	$15.95 - $25.18 $507,353 - $800,950	-31,809 Reduced 15.71%	170,681 $3.18 Million
Q4 2022 Feb 13, 2023	BUY	$13.27 - $17.73 $110,379 - $147,478	8,318 Added 4.28%	202,490 $3.24 Million
Q3 2022 Nov 03, 2022	BUY	$11.4 - $14.6 $2.16 Million - $2.77 Million	189,783 Added 4324.06%	194,172 $2.53 Million
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $79,217 - $129,301	-9,977 Reduced 69.45%	4,389 $46,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $1.08 Million - $1.51 Million	-90,155 Reduced 86.26%	14,366 $173,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $679,450 - $1.05 Million	68,424 Added 189.56%	104,521 $1.47 Million
Q3 2021 Nov 09, 2021	BUY	$10.18 - $26.64 $250,682 - $656,010	24,625 Added 214.65%	36,097 $369,000
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $1.6 Million - $3.06 Million	-85,894 Reduced 88.22%	11,472 $306,000
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $1.78 Million - $3.19 Million	57,315 Added 143.11%	97,366 $3.38 Million
Q4 2020 Feb 11, 2021	SELL	$37.09 - $48.97 $453,796 - $599,147	-12,235 Reduced 23.4%	40,051 $1.49 Million
Q3 2020 Nov 12, 2020	SELL	$40.47 - $45.5 $347,232 - $390,390	-8,580 Reduced 14.1%	52,286 $2.15 Million
Q2 2020 Aug 12, 2020	SELL	$32.57 - $42.83 $2.6 Million - $3.41 Million	-79,684 Reduced 56.69%	60,866 $2.47 Million
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $1.12 Million - $2.22 Million	-48,244 Reduced 25.55%	140,550 $4.89 Million
Q4 2019 Feb 10, 2020	BUY	$34.58 - $48.06 $1.21 Million - $1.68 Million	34,864 Added 22.65%	188,794 $8.1 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $74,033 - $96,996	-2,002 Reduced 1.28%	153,930 $5.69 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $3.7 Million - $5.86 Million	105,455 Added 208.92%	155,932 $7.05 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $1.85 Million - $2.59 Million	43,277 Added 601.07%	50,477 $2.74 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $1.28 Million - $2.03 Million	-33,742 Reduced 82.41%	7,200 $333,000
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $2 Million - $2.39 Million	35,466 Added 647.66%	40,942 $2.49 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $867,198 - $1.25 Million	-19,314 Reduced 77.91%	5,476 $342,000
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $535,447 - $727,901	11,807 Added 90.94%	24,790 $1.15 Million
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $467,281 - $669,453	11,139 Added 604.07%	12,983 $616,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $61,589 - $99,391	1,844	1,844 $99,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$4.76 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$3.26 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.82 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.87 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$1.16 Million
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $45M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account